- Home
- AMBC vs TECX Comparison
AMBC vs TECX Comparison
Compare AMBC & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- TECX
- Stock Information
- Founded
- AMBC 1971
- TECX 2019
- Country
- AMBC United States
- TECX United States
- Employees
- AMBC N/A
- TECX N/A
- Industry
- AMBC Property-Casualty Insurers
- TECX
- Sector
- AMBC Finance
- TECX
- Exchange
- AMBC Nasdaq
- TECX Nasdaq
- Market Cap
- AMBC 411.3M
- TECX 334.4M
- IPO Year
- AMBC 1991
- TECX 2018
- Fundamental
- Price
- AMBC $7.19
- TECX $21.69
- Analyst Decision
- AMBC Strong Buy
- TECX Buy
- Analyst Count
- AMBC 1
- TECX 6
- Target Price
- AMBC $15.00
- TECX $78.67
- AVG Volume (30 Days)
- AMBC 940.8K
- TECX 241.7K
- Earning Date
- AMBC 08-04-2025
- TECX 08-13-2025
- Dividend Yield
- AMBC N/A
- TECX N/A
- EPS Growth
- AMBC N/A
- TECX N/A
- EPS
- AMBC N/A
- TECX N/A
- Revenue
- AMBC $253,912,000.00
- TECX N/A
- Revenue This Year
- AMBC N/A
- TECX N/A
- Revenue Next Year
- AMBC $17.41
- TECX N/A
- P/E Ratio
- AMBC N/A
- TECX N/A
- Revenue Growth
- AMBC 125.08
- TECX N/A
- 52 Week Low
- AMBC $5.99
- TECX $13.70
- 52 Week High
- AMBC $13.64
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- AMBC 49.52
- TECX 51.82
- Support Level
- AMBC $6.97
- TECX $19.13
- Resistance Level
- AMBC $7.22
- TECX $21.46
- Average True Range (ATR)
- AMBC 0.27
- TECX 1.27
- MACD
- AMBC 0.06
- TECX -0.00
- Stochastic Oscillator
- AMBC 90.79
- TECX 70.50
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.